Medicover Q4 revenue rises 10%, net profit more than doubles

Medicover AB

10/02/2026 06:54

Overview

Healthcare services firm's Q4 revenue rose 10% yr/yr, driven by organic growth

Operating profit for Q4 increased 50% yr/yr, reflecting improved margins

Net profit for Q4 more than doubled yr/yr, showcasing enhanced profitability

Outlook

Medicover targets organic revenue exceeding €3.25 bln by 2028

Company aims for adjusted organic EBITDA over €600 mln by 2028

Medicover plans to expand network and increase capacity utilization

Result Drivers

ORGANIC GROWTH - Medicover's Q4 revenue growth was driven by organic expansion and acquisitions, with continued demand for healthcare services

COST CONTROL - Improved margins and cost control contributed to Medicover's increased profitability in Q4

POLAND OPERATIONS - Sports/wellness and ambulatory business in Poland were key contributors to revenue and profit growth in Q4

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
EUR 611.70 mln
Q4 Net Income
EUR 17.30 mln
Q4 Basic EPS
EUR 0.12
Q4 EBIT
EUR 35.20 mln
Q4 EBIT Margin
5.70%


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy"

Wall Street's median 12-month price target for Medicover AB is SEK251.50, about 24.2% above its February 9 closing price of SEK202.50

The stock recently traded at 27 times the next 12-month earnings vs. a P/E of 35 three months ago

Press Release: ID:nMFN99qPzC

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)